Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

AMNEAL PHARMACEUTICALS, INC. (AMRX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

AMNEAL PHARMACEUTICALS, INC. (AMRX), most recent 12 months reported: revenue $3.12B, net income $157.36M, free cash flow $127.83M. Latest balance sheet on file: liquid cash $127.64M, total debt $2.67B, net cash -$2.54B. From SEC filings. Others in Pharmaceutical Preparations: Jazz Pharmaceuticals plc · Perrigo Company plc · BIOMARIN PHARMACEUTICAL INC · United Therapeutics Corporation · Royalty Pharma plc · SAREPTA THERAPEUTICS, INC. · Alkermes plc. · Phibro Animal Health Corporation

Stock screener

Watchlist